Search
Crescent Biopharma Ord Shs
CBIOAdd to Watchlist
17.090USD
+0.010+0.06%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
237.42MMarket Cap
LossP/E TTM
Crescent Biopharma Ord Shs Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
10.84M
--
EPS(YoY)
-14.97
74.51%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its current assets were 236.66M, with a year-on-year change of 2033.67.
What are the total assets of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its total assets of Crescent Biopharma Ord Shs were 240.29M, with a year-on-year change of 2066.47.
What are the total liabilities of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its total liabilities of Crescent Biopharma Ord Shs were 37.28M, with a year-on-year change of 545.24.
What is the total equity of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its total equity of Crescent Biopharma Ord Shs was 203.01M, with a year-on-year change of 3720.64.
What is the net investment of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its net investment of Crescent Biopharma Ord Shs was -72.92M, with a year-on-year change of -364185.28.
What is the net financing of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its net financing of Crescent Biopharma Ord Shs was 322.98M, with a year-on-year change of 5983301.26.
What is the Earnings Per Share (EPS) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -14.97, with a year-on-year change of 74.51.
What is the Return on Equity (ROE) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its Return on Equity (ROE) was -152.64, with a year-on-year change of 11.90.
What is the Return on Assets (ROA) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -124.07, with a year-on-year change of 7.62.
What is the operating profit of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its operating profit was -145.43M, with a year-on-year change of -347.34.